Rapid Micro Ownership
| RPID Stock | USD 3.99 0.59 17.35% |
Shares in Circulation | First Issued 2019-12-31 | Previous Quarter 43.8 M | Current Value 44 M | Avarage Shares Outstanding 39.4 M | Quarterly Volatility 5.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapid Micro Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. Rapid Stock Ownership Analysis
About 61.0% of the company shares are owned by institutional investors. The book value of Rapid Micro was at this time reported as 1.5. The company recorded a loss per share of 1.03. Rapid Micro Biosystems had not issued any dividends in recent years. The entity had 1:30 split on the 29th of October 2010. Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts. Rapid Micro operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people. To find out more about Rapid Micro Biosystems contact Robert Spignesi at 978 349 3200 or learn more at https://www.rapidmicrobio.com.Besides selling stocks to institutional investors, Rapid Micro also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Rapid Micro's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Rapid Micro's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Rapid Micro Quarterly Liabilities And Stockholders Equity |
|
Rapid Micro Insider Trades History
About 11.0% of Rapid Micro Biosystems are currently held by insiders. Unlike Rapid Micro's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Rapid Micro's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Rapid Micro's insider trades
Rapid Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Rapid Micro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rapid Micro Biosystems backward and forwards among themselves. Rapid Micro's institutional investor refers to the entity that pools money to purchase Rapid Micro's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2025-03-31 | 110.6 K | Omers Administration Corp | 2025-03-31 | 109.4 K | Essex Investment Management Company, Llc | 2025-03-31 | 63.1 K | State Street Corp | 2025-03-31 | 59.9 K | Northern Trust Corp | 2025-03-31 | 45.6 K | Mariner Wealth Advisors Llc | 2025-03-31 | 31.9 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 21.2 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 19.6 K | Legato Capital Management Llc | 2025-03-31 | 15.4 K | Bain Capital Life Sciences Investors, Llc | 2025-03-31 | 8.4 M | Abg-wtt Global Life Science Capital Partners Gp Ltd | 2025-03-31 | 1.8 M |
Rapid Micro Biosystems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rapid Micro insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rapid Micro's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rapid Micro insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rapid Micro Outstanding Bonds
Rapid Micro issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rapid Micro Biosystems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rapid bonds can be classified according to their maturity, which is the date when Rapid Micro Biosystems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Rapid Micro Biosystems is a strong investment it is important to analyze Rapid Micro's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rapid Micro's future performance. For an informed investment choice regarding Rapid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapid Micro Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.03) | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.